Microsoft has released ASP.NET Core in .NET 11 Preview 1, introducing new Blazor components like EnvironmentBoundary, Label, and DisplayName, along with relative URI navigation, QuickGrid row click ...

Understand the key advantages of Razor Pages in ASP.NET Core for building real-world web applications Learn how features like dependency injection, configuration, and environment awareness improve ...

The way software is developed has undergone multiple sea changes over the past few decades. From assembly language to cloud-native development, from monolithic architecture to microservices, from ...

The August 2025 update for Visual Studio 2022 is now out, offering new AI capabilities and even ways to scale back AI interference in the IDE. Although Visual Studio Code is a very useful lightweight ...

If you use Visual Studio Code, the April 2025 update (version 1.100) is worth checking out. This release brings smarter AI, faster Chat responses, a new GPT model, and small but useful improvements to ...

If you want to set and use Deepseek-R1 in Visual Studio Code, follow the steps below. Install Visual Studio Code Download Ollama Install the CodeGPT Extension Install DeepSeek models Use DeepSeek in ...

Microsoft Threat Intelligence has identified 3,000 ASP.NET keys disclosed in code documentation and repos that could be used in code injection attacks. Microsoft Threat Intelligence in December ...

Microsoft warns that attackers are deploying malware in ViewState code injection attacks using static ASP. NET machine keys found online. As Microsoft Threat Intelligence experts recently discovered, ...

In December 2024, Microsoft Threat Intelligence observed limited activity by an unattributed threat actor using a publicly available, static ASP.NET machine key to inject malicious code and deliver ...

Use Visual Studio to create an Azure resource group project and deploy the resources to Azure. With Visual Studio, you can create a project that deploys your infrastructure and code to Azure. For ...

Efficacy, Safety, Pharmacokinetics, and Immunogenicity of DRL-Trastuzumab Versus Herceptin in Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer: A Randomized Controlled Trial ...